NEUROCRINE BIOSCIENCES INC
NBIX
71 insider filings · Latest: Sep 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Sep 15 9:03 PM | David W. BoyerChief Corp. Affairs Officer | Sale | 826 | $157.45 | $130.1K | 8,722(D) | View → |
| Sep 14, 2026 | Sep 15 9:02 PM | Matt AbernethyChief Financial Officer | Sale | 2,311 | $157.20 | $363.3K | 42,808(D) | View → |
| Sep 14, 2026 | Sep 14 8:49 PM | MATTHEW C ABERNETHY | Proposed Sale | 2,311 | $156.22 | $361.0K | — | View → |
| Sep 14, 2026 | Sep 14 8:39 PM | DAVID WARREN BOYER | Proposed Sale | 4,714 | $156.22 | $736.4K | — | View → |
| Sep 9, 2026 | Sep 11 12:29 AM | Eric BenevichChief Commercial Officer | Sale | 2,154 | $154.61 | $333.0K | 64,408(D) | View → |
| Sep 9, 2026 | Sep 9 8:19 PM | ERIC BENEVICH | Proposed Sale | 2,154 | $155.13 | $334.2K | — | View → |
| Jul 28, 2026 | Jul 30 9:29 PM | Leslie V NorwalkDirector | Sale | 1,250 | $182.01 | $227.5K | 1,588(D) | View → |
| Jul 10, 2026 | Jul 13 8:27 PM | Ingrid DelaetChief Regulatory Officer | Sale | 4,367 | $181.02 | $790.5K | 16,225(D) | View → |
| Jul 9, 2026 | Jul 13 8:27 PM | Darin LippoldtChief Legal Officer | Sale | 10,000 | $179.60 | $1.8M | 54,729(D) | View → |
| Jul 10, 2026 | Jul 10 8:39 PM | INGRID DELAET | Proposed Sale | 4,367 | $180.55 | $788.5K | — | View → |
| Jul 9, 2026 | Jul 9 10:41 PM | Ingrid DelaetChief Regulatory Officer | Sale | 8,433 | $178.72 | $1.5M | 16,225(D) | View → |
| Jul 8, 2026 | Jul 9 10:41 PM | Ingrid DelaetChief Regulatory Officer | Sale | 2,737 | $178.54 | $488.7K | 16,225(D) | View → |
| Jul 7, 2026 | Jul 9 10:41 PM | Ingrid DelaetChief Regulatory Officer | Sale | 3,401 | $178.57 | $607.3K | 16,225(D) | View → |
| Jul 9, 2026 | Jul 9 8:27 PM | DARIN LIPPOLDT | Proposed Sale | 10,000 | $178.24 | $1.8M | — | View → |
| Jul 7, 2026 | Jul 7 8:33 PM | INGRID DELAET | Proposed Sale | 14,571 | $174.10 | $2.5M | — | View → |
| Jun 29, 2026 | Jun 30 8:52 PM | Darin LippoldtChief Legal Officer | Sale | 9,800 | $170.16 | $1.7M | 54,729(D) | View → |
| Jun 26, 2026 | Jun 30 8:52 PM | Darin LippoldtChief Legal Officer | Sale | 200 | $169.57 | $33.9K | 54,729(D) | View → |
| Jun 29, 2026 | Jun 29 8:43 PM | DARIN LIPPOLDT | Proposed Sale | 9,800 | $168.52 | $1.7M | — | View → |
| Jun 26, 2026 | Jun 26 8:25 PM | DARIN LIPPOLDT | Proposed Sale | 200 | $164.18 | $32.8K | — | View → |
| Jun 5, 2026 | Jun 9 9:40 PM | SHERWIN STEPHEN ADirector | Sale | 25,000 | $165.32 | $4.1M | 15,860(D) | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 17 10:44 PM | Kevin Charles GormanDirector | Option Exercise | 10,981 | — | 5,377(D) | View → |
| Feb 13, 2026 | Feb 17 10:44 PM | Sanjay Chandru KeswaniChief Medical Officer | Grant/Award | 42,112 | $124.12 | 6,285(D) | View → |
| Jan 31, 2026 | Feb 3 11:22 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 2,096 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:21 PM | Eric BenevichChief Commercial Officer | Option Exercise | 2,294 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:06 PM | Matt AbernethyChief Financial Officer | Option Exercise | 2,437 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:05 PM | Julie CookeChief Human Resources Officer | Option Exercise | 1,741 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:04 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 801 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:03 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 2,927 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:02 PM | Kevin Charles GormanDirector | Option Exercise | 5,142 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Darin LippoldtChief Legal Officer | Option Exercise | 2,373 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 238 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 36,400 | $35.99 | 0(D) | View → |
← Previous
Page 4 of 4